[mc4wp_form]
FEATURED NEWS
Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model
A Breakthrough in COVID-19 Therapeutics: Synergistic Targeting of SARS-CoV-2 PLpro and Host RIPK1 Yields Promising Results in Preclinical Models The...
Neg-Entropy: The Key Therapeutic Target for Chronic Diseases
In a groundbreaking publication in Acta Pharmaceutica Sinica B, researchers have introduced a transformative paradigm for understanding and treating chronic...
Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease
Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: A Landmark Evidence-Based Guideline In the ever-evolving landscape of inflammatory bowel...
Early Tuberculosis Treatment Lowers Sepsis Mortality in People with HIV
Sepsis remains one of the most formidable challenges in global health, representing a critical condition where the body’s overwhelming immune response to infection leads to tissue damage, organ failure,...
Hospitalized Older Adults: Insights from Rwandan Teaching Hospitals
Title: Understanding the Complexities of Hospitalized Older Adults in Rwanda: A Comprehensive Exploration In a remarkable study, researchers have delved...
Afuresertib and Fulvestrant Trial for Advanced Breast Cancer
In a compelling advancement for the treatment landscape of advanced breast cancer, researchers have unveiled promising results from a phase...
Targeted Epigenetic Therapy Boosts Pancreatic Cancer Immunity
A groundbreaking study has unveiled a promising therapeutic avenue for one of the most lethal forms of cancer—pancreatic ductal adenocarcinoma...
OPINIONS
FOLLOW US
NATIONAL
No Content Available
POLITICS
No Content Available
TECH
No Content Available
LIFESTYLE
No Content Available